New Anti-Chemokine Oral Drug XC8 in Treatment of Asthma Patients with Poor Response to Corticosteroids: Results of a Phase 2A Randomized Controlled Clinical Trial
figureposted on 2020-10-20, 09:09 authored by Julia Romanova, Elena Chikina, Anastasia Rydlovskaya, Wolfgang Pohl, Andreas Renner, Alexey Zeifman, Alexander Chuchalin, Vladimir Nebolsin
Article full text
The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.